Variable short duration treatment versus standard treatment, with and without adjunctive ribavirin, for chronic hepatitis C: the STOP-HCV-1 non-inferiority, factorial RCT
Saved in:
| Title: | Variable short duration treatment versus standard treatment, with and without adjunctive ribavirin, for chronic hepatitis C: the STOP-HCV-1 non-inferiority, factorial RCT |
|---|---|
| Authors: | Cooke GS; Department of Infectious Disease, Imperial College London, London, UK; Imperial College Healthcare NHS Trust, London, UK, Pett S; MRC Clinical Trials Unit, University College London, London, UK; Mortimer Market Centre, Central and North West London NHS Foundation Trust, London, UK; Institute for Global Health, University College London, London, UK, McCabe L; MRC Clinical Trials Unit, University College London, London, UK, Jones C; Department of Infectious Disease, Imperial College London, London, UK; Imperial College Healthcare NHS Trust, London, UK, Gilson R; Mortimer Market Centre, Central and North West London NHS Foundation Trust, London, UK; Institute for Global Health, University College London, London, UK, Verma S; Hepatology, Brighton and Sussex Medical School, Brighton and Sussex University Hospitals, Brighton, UK, Ryder SD; NIHR Nottingham Biomedical Research Centre, Nottingham University Hospitals, University of Nottingham, Nottingham, UK, Collier JD; Department of Gastroenterology, John Radcliffe Hospital, Oxford, UK, Barclay ST; Gastroenterology, Glasgow Royal Infirmary, Glasgow, UK, Ala A; Department of Clinical and Experimental Medicine, University of Surrey, Guildford, UK, Bhagani S; Infectious Diseases, Royal Free London NHS Foundation Trust, London, UK, Nelson M; Kobler Unit, Chelsea and Westminster Hospital, London, UK, Ch’Ng CL; Swansea Bay University Health Board, Port Talbot, UK, Stone B; Infectious Diseases, Sheffield Teaching Hospitals NHS Trust, Sheffield, UK, Wiselka M; University Hospitals of Leicester NHS Trust, Leicester, UK, Forton D; Hepatology, St George’s University Hospitals NHS Foundation Trust, London, UK, McPherson S; Hepatology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK, Halford R; Hepatitis C Trust, London, UK, Nguyen D; Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, UK, Smith D; Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, UK, Ansari MA; Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, UK, Ainscough H; MRC Clinical Trials Unit, University College London, London, UK, Dennis E; MRC Clinical Trials Unit, University College London, London, UK, Hudson F; MRC Clinical Trials Unit, University College London, London, UK, Barnes EJ; Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, UK; Translational Gastroenterology Unit, University of Oxford, Oxford, UK, Walker AS; MRC Clinical Trials Unit, University College London, London, UK |
| Corporate Authors: | the STOP-HCV trial team |
| Source: | 2021 Oct. |
| Source: | Efficacy and Mechanism Evaluation |
| Publication Type: | Review |
| Journal Info: | Publisher: NIHR Journals Library |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 34723451 AccessLevel: 2 PubType: Review PubTypeId: review PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Variable short duration treatment versus standard treatment, with and without adjunctive ribavirin, for chronic hepatitis C: the STOP-HCV-1 non-inferiority, factorial RCT – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Cooke+GS%22">Cooke GS</searchLink>; Department of Infectious Disease, Imperial College London, London, UK; Imperial College Healthcare NHS Trust, London, UK<br /><searchLink fieldCode="AU" term="%22Pett+S%22">Pett S</searchLink>; MRC Clinical Trials Unit, University College London, London, UK; Mortimer Market Centre, Central and North West London NHS Foundation Trust, London, UK; Institute for Global Health, University College London, London, UK<br /><searchLink fieldCode="AU" term="%22McCabe+L%22">McCabe L</searchLink>; MRC Clinical Trials Unit, University College London, London, UK<br /><searchLink fieldCode="AU" term="%22Jones+C%22">Jones C</searchLink>; Department of Infectious Disease, Imperial College London, London, UK; Imperial College Healthcare NHS Trust, London, UK<br /><searchLink fieldCode="AU" term="%22Gilson+R%22">Gilson R</searchLink>; Mortimer Market Centre, Central and North West London NHS Foundation Trust, London, UK; Institute for Global Health, University College London, London, UK<br /><searchLink fieldCode="AU" term="%22Verma+S%22">Verma S</searchLink>; Hepatology, Brighton and Sussex Medical School, Brighton and Sussex University Hospitals, Brighton, UK<br /><searchLink fieldCode="AU" term="%22Ryder+SD%22">Ryder SD</searchLink>; NIHR Nottingham Biomedical Research Centre, Nottingham University Hospitals, University of Nottingham, Nottingham, UK<br /><searchLink fieldCode="AU" term="%22Collier+JD%22">Collier JD</searchLink>; Department of Gastroenterology, John Radcliffe Hospital, Oxford, UK<br /><searchLink fieldCode="AU" term="%22Barclay+ST%22">Barclay ST</searchLink>; Gastroenterology, Glasgow Royal Infirmary, Glasgow, UK<br /><searchLink fieldCode="AU" term="%22Ala+A%22">Ala A</searchLink>; Department of Clinical and Experimental Medicine, University of Surrey, Guildford, UK<br /><searchLink fieldCode="AU" term="%22Bhagani+S%22">Bhagani S</searchLink>; Infectious Diseases, Royal Free London NHS Foundation Trust, London, UK<br /><searchLink fieldCode="AU" term="%22Nelson+M%22">Nelson M</searchLink>; Kobler Unit, Chelsea and Westminster Hospital, London, UK<br /><searchLink fieldCode="AU" term="%22Ch%27Ng+CL%22">Ch’Ng CL</searchLink>; Swansea Bay University Health Board, Port Talbot, UK<br /><searchLink fieldCode="AU" term="%22Stone+B%22">Stone B</searchLink>; Infectious Diseases, Sheffield Teaching Hospitals NHS Trust, Sheffield, UK<br /><searchLink fieldCode="AU" term="%22Wiselka+M%22">Wiselka M</searchLink>; University Hospitals of Leicester NHS Trust, Leicester, UK<br /><searchLink fieldCode="AU" term="%22Forton+D%22">Forton D</searchLink>; Hepatology, St George’s University Hospitals NHS Foundation Trust, London, UK<br /><searchLink fieldCode="AU" term="%22McPherson+S%22">McPherson S</searchLink>; Hepatology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK<br /><searchLink fieldCode="AU" term="%22Halford+R%22">Halford R</searchLink>; Hepatitis C Trust, London, UK<br /><searchLink fieldCode="AU" term="%22Nguyen+D%22">Nguyen D</searchLink>; Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, UK<br /><searchLink fieldCode="AU" term="%22Smith+D%22">Smith D</searchLink>; Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, UK<br /><searchLink fieldCode="AU" term="%22Ansari+MA%22">Ansari MA</searchLink>; Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, UK<br /><searchLink fieldCode="AU" term="%22Ainscough+H%22">Ainscough H</searchLink>; MRC Clinical Trials Unit, University College London, London, UK<br /><searchLink fieldCode="AU" term="%22Dennis+E%22">Dennis E</searchLink>; MRC Clinical Trials Unit, University College London, London, UK<br /><searchLink fieldCode="AU" term="%22Hudson+F%22">Hudson F</searchLink>; MRC Clinical Trials Unit, University College London, London, UK<br /><searchLink fieldCode="AU" term="%22Barnes+EJ%22">Barnes EJ</searchLink>; Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, UK; Translational Gastroenterology Unit, University of Oxford, Oxford, UK<br /><searchLink fieldCode="AU" term="%22Walker+AS%22">Walker AS</searchLink>; MRC Clinical Trials Unit, University College London, London, UK – Name: AuthorCorporate Label: Corporate Authors Group: Au Data: <searchLink fieldCode="CA" term="%22the+STOP-HCV+trial+team%22">the STOP-HCV trial team</searchLink> – Name: TitleSource Label: Source Group: Src Data: 2021 Oct. – Name: TitleSource Label: Source Group: Src Data: Efficacy and Mechanism Evaluation – Name: TypePub Label: Publication Type Group: TypPub Data: Review – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22NIHR+Journals+Library%22">NIHR Journals Library </searchLink> |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34723451 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3310/eme08170 Languages: – Code: eng Text: English Titles: – TitleFull: Variable short duration treatment versus standard treatment, with and without adjunctive ribavirin, for chronic hepatitis C: the STOP-HCV-1 non-inferiority, factorial RCT Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Cooke GS – PersonEntity: Name: NameFull: Pett S – PersonEntity: Name: NameFull: McCabe L – PersonEntity: Name: NameFull: Jones C – PersonEntity: Name: NameFull: Gilson R – PersonEntity: Name: NameFull: Verma S – PersonEntity: Name: NameFull: Ryder SD – PersonEntity: Name: NameFull: Collier JD – PersonEntity: Name: NameFull: Barclay ST – PersonEntity: Name: NameFull: Ala A – PersonEntity: Name: NameFull: Bhagani S – PersonEntity: Name: NameFull: Nelson M – PersonEntity: Name: NameFull: Ch’Ng CL – PersonEntity: Name: NameFull: Stone B – PersonEntity: Name: NameFull: Wiselka M – PersonEntity: Name: NameFull: Forton D – PersonEntity: Name: NameFull: McPherson S – PersonEntity: Name: NameFull: Halford R – PersonEntity: Name: NameFull: Nguyen D – PersonEntity: Name: NameFull: Smith D – PersonEntity: Name: NameFull: Ansari MA – PersonEntity: Name: NameFull: Ainscough H – PersonEntity: Name: NameFull: Dennis E – PersonEntity: Name: NameFull: Hudson F – PersonEntity: Name: NameFull: Barnes EJ – PersonEntity: Name: NameFull: Walker AS IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 10 Text: 2021 Oct Type: published Y: 2021 |
| ResultId | 1 |